Galectin-9 Ameliorates Clinical Severity of MRL/lpr Lupus-Prone Mice by Inducing Plasma Cell Apoptosis Independently of Tim-3-Reference-Cited by-同舟云学术

Galectin-9 Ameliorates Clinical Severity of MRL/lpr Lupus-Prone Mice by Inducing Plasma Cell Apoptosis Independently of Tim-3

Published:2013-04-09 Issue:4 Volume:8 Page:e60807
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Moritoki Masahiro,Kadowaki Takeshi,Niki Toshiro,Nakano Daisuke,Soma Genichiro,Mori Hirohito,Kobara Hideki,Masaki Tsutomu,Kohno Masakazu,Hirashima Mitsuomi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Lupus nephritis in Colombians: contrasts and comparisons with other populations;JM Anaya;Clin Rev Allergy Immunol,2011

2. The Rationale for BAFF Inhibition in Systemic Lupus Erythematosus;A Davidson;Curr Rheumatol Rep,2012

3. BAFF and selection of autoreactive B cells;Z Liu;Trends Immunol,2011

4. BAFF inhibition: a new class of drugs for the treatment of autoimmunity;Z Liu;Exp Cell Res,2011

5. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis;M Seki;Clin Immunol,2008

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating CD8 + LGALS9 + T Cell Population Exhibiting Low Cytotoxic Characteristics are Decreased in Patients with Systemic Lupus Erythematosus;Immunologic Research;2024-07-24

2. Clinical utility of serum Galactin-9 in evaluation of systemic lupus erythematosus patients;The Egyptian Rheumatologist;2024-01

3. Targeting immune checkpoints in anti-neutrophil cytoplasmic antibodies associated vasculitis: the potential therapeutic targets in the future;Frontiers in Immunology;2023-04-06

4. Galectin-9: A novel promoter of atherosclerosis progression;Atherosclerosis;2022-12

5. Serum and urinary galectin-9 and C-X-C motif chemokine ligand 10;Lupus;2022-03-04